TTN and myocarditis: A majority of published experimental models of cardiac disease (myocarditis, diabetes, ischemia) presented with reduced total titin phosphorylation and increased myocardial stiffness compared with healthy controls, possibly driven by hypophosphorylation of residues in the N2-Bus segment (reviewed in ref. 9).